![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:CDKAL1-FARS2 (FusionGDB2 ID:HG54901TG10667) |
Fusion Gene Summary for CDKAL1-FARS2 |
![]() |
Fusion gene information | Fusion gene name: CDKAL1-FARS2 | Fusion gene ID: hg54901tg10667 | Hgene | Tgene | Gene symbol | CDKAL1 | FARS2 | Gene ID | 54901 | 10667 |
Gene name | CDK5 regulatory subunit associated protein 1 like 1 | phenylalanyl-tRNA synthetase 2, mitochondrial | |
Synonyms | - | COXPD14|FARS1|HSPC320|PheRS|SPG77|mtPheRS | |
Cytomap | ('CDKAL1')('FARS2') 6p22.3 | 6p25.1 | |
Type of gene | protein-coding | protein-coding | |
Description | threonylcarbamoyladenosine tRNA methylthiotransferasetRNA-t(6)A37 methylthiotransferase | phenylalanine--tRNA ligase, mitochondrialdJ236A3.1 (phenylalanine-tRNA synthetase)dJ520B18.2 (FARS1 (phenylalanine-tRNA synthetase))mitochondrial PHERSphenylalanine tRNA ligase 2, mitochondrialphenylalanine translasephenylalanine-tRNA synthetase 1 ( | |
Modification date | 20200322 | 20200313 | |
UniProtAcc | Q5VV42 | . | |
Ensembl transtripts involved in fusion gene | ENST00000274695, ENST00000378610, ENST00000378624, ENST00000476517, | ||
Fusion gene scores | * DoF score | 37 X 20 X 14=10360 | 15 X 13 X 10=1950 |
# samples | 39 | 21 | |
** MAII score | log2(39/10360*10)=-4.73140606882431 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(21/1950*10)=-3.21501289097085 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CDKAL1 [Title/Abstract] AND FARS2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CDKAL1(21065459)-FARS2(5771524), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | CDKAL1-FARS2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CDKAL1-FARS2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CDKAL1-FARS2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CDKAL1-FARS2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CDKAL1-FARS2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | FARS2 | GO:0006432 | phenylalanyl-tRNA aminoacylation | 10329163 |
Tgene | FARS2 | GO:0008033 | tRNA processing | 10329163 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-VQ-AA68-01A | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + |
Top |
Fusion Gene ORF analysis for CDKAL1-FARS2 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000274695 | ENST00000274680 | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + |
Frame-shift | ENST00000378610 | ENST00000274680 | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + |
Frame-shift | ENST00000378624 | ENST00000274680 | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + |
In-frame | ENST00000274695 | ENST00000324331 | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + |
In-frame | ENST00000378610 | ENST00000324331 | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + |
In-frame | ENST00000378624 | ENST00000324331 | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + |
intron-3CDS | ENST00000476517 | ENST00000274680 | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + |
intron-3CDS | ENST00000476517 | ENST00000324331 | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000274695 | CDKAL1 | chr6 | 21065459 | + | ENST00000324331 | FARS2 | chr6 | 5771524 | + | 1542 | 1403 | 167 | 1540 | 458 |
ENST00000378624 | CDKAL1 | chr6 | 21065459 | + | ENST00000324331 | FARS2 | chr6 | 5771524 | + | 1429 | 1290 | 264 | 1427 | 388 |
ENST00000378610 | CDKAL1 | chr6 | 21065459 | + | ENST00000324331 | FARS2 | chr6 | 5771524 | + | 1385 | 1246 | 10 | 1383 | 458 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000274695 | ENST00000324331 | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + | 0.2582267 | 0.74177337 |
ENST00000378624 | ENST00000324331 | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + | 0.19087532 | 0.80912465 |
ENST00000378610 | ENST00000324331 | CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771524 | + | 0.5636952 | 0.4363048 |
Top |
Fusion Genomic Features for CDKAL1-FARS2 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771523 | + | 9.96E-13 | 1 |
CDKAL1 | chr6 | 21065459 | + | FARS2 | chr6 | 5771523 | + | 9.96E-13 | 1 |
![]() |
![]() |
![]() |
![]() |
Top |
Fusion Protein Features for CDKAL1-FARS2 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr6:21065459/chr6:5771524) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
CDKAL1 | . |
FUNCTION: Catalyzes the methylthiolation of N6-threonylcarbamoyladenosine (t(6)A), leading to the formation of 2-methylthio-N6-threonylcarbamoyladenosine (ms(2)t(6)A) at position 37 in tRNAs that read codons beginning with adenine. {ECO:0000250|UniProtKB:Q91WE6}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000274695 | + | 12 | 16 | 64_172 | 412 | 580.0 | Domain | MTTase N-terminal |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000378610 | + | 10 | 14 | 64_172 | 412 | 580.0 | Domain | MTTase N-terminal |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000378624 | + | 11 | 14 | 64_172 | 342 | 489.0 | Domain | MTTase N-terminal |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000274695 | + | 12 | 16 | 200_431 | 412 | 580.0 | Domain | Radical SAM core |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000274695 | + | 12 | 16 | 431_493 | 412 | 580.0 | Domain | TRAM |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000378610 | + | 10 | 14 | 200_431 | 412 | 580.0 | Domain | Radical SAM core |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000378610 | + | 10 | 14 | 431_493 | 412 | 580.0 | Domain | TRAM |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000378624 | + | 11 | 14 | 200_431 | 342 | 489.0 | Domain | Radical SAM core |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000378624 | + | 11 | 14 | 431_493 | 342 | 489.0 | Domain | TRAM |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000274695 | + | 12 | 16 | 556_578 | 412 | 580.0 | Transmembrane | Helical |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000378610 | + | 10 | 14 | 556_578 | 412 | 580.0 | Transmembrane | Helical |
Hgene | CDKAL1 | chr6:21065459 | chr6:5771524 | ENST00000378624 | + | 11 | 14 | 556_578 | 342 | 489.0 | Transmembrane | Helical |
Tgene | FARS2 | chr6:21065459 | chr6:5771524 | ENST00000274680 | 5 | 7 | 358_450 | 405 | 452.0 | Domain | FDX-ACB | |
Tgene | FARS2 | chr6:21065459 | chr6:5771524 | ENST00000324331 | 5 | 7 | 358_450 | 405 | 452.0 | Domain | FDX-ACB | |
Tgene | FARS2 | chr6:21065459 | chr6:5771524 | ENST00000274680 | 5 | 7 | 157_160 | 405 | 452.0 | Region | Note=Substrate binding | |
Tgene | FARS2 | chr6:21065459 | chr6:5771524 | ENST00000274680 | 5 | 7 | 186_188 | 405 | 452.0 | Region | Note=Substrate binding | |
Tgene | FARS2 | chr6:21065459 | chr6:5771524 | ENST00000274680 | 5 | 7 | 193_195 | 405 | 452.0 | Region | Note=Substrate binding | |
Tgene | FARS2 | chr6:21065459 | chr6:5771524 | ENST00000324331 | 5 | 7 | 157_160 | 405 | 452.0 | Region | Note=Substrate binding | |
Tgene | FARS2 | chr6:21065459 | chr6:5771524 | ENST00000324331 | 5 | 7 | 186_188 | 405 | 452.0 | Region | Note=Substrate binding | |
Tgene | FARS2 | chr6:21065459 | chr6:5771524 | ENST00000324331 | 5 | 7 | 193_195 | 405 | 452.0 | Region | Note=Substrate binding |
Top |
Fusion Gene Sequence for CDKAL1-FARS2 |
![]() |
>15331_15331_1_CDKAL1-FARS2_CDKAL1_chr6_21065459_ENST00000274695_FARS2_chr6_5771524_ENST00000324331_length(transcript)=1542nt_BP=1403nt AAATAAACGTGGCGGGACGTATGTGTCATGGCGCTCTCCATCTAAAGTCTGTGCAGCTTCCGGAGAGTGGCGGGTTGATTTTCTCACTTT GGACTGGTTTTTACTTCCCGACTTCTGGACTCATCTTTCAAGAGGACTTTAGACTAATTGCAGATAATTAAGAGAATATGCCTTCTGCAT CCTGTGATACACTACTGGATGACATCGAAGATATCGTGTCTCAGGAAGATTCAAAACCACAAGATAGGCATTTTGTAAGAAAGGATGTTG TCCCGAAGGTACGAAGGCGAAATACCCAAAAATATTTGCAAGAGGAAGAAAACAGTCCACCAAGTGACAGCACTATTCCAGGCATACAGA AAATTTGGATACGAACATGGGGTTGTTCTCATAATAATTCAGATGGAGAATATATGGCTGGACAGCTAGCTGCTTATGGCTATAAAATTA CAGAAAATGCATCCGATGCAGATTTATGGCTCCTGAACAGTTGCACTGTAAAAAACCCAGCTGAAGACCACTTTAGAAACTCAATTAAAA AAGCTCAAGAGGAGAACAAGAAAATCGTACTGGCTGGATGCGTTCCTCAAGCCCAGCCTCGCCAGGACTACCTTAAGGGACTGAGTATCA TTGGGGTTCAGCAGATAGATCGTGTGGTAGAAGTTGTGGAGGAGACAATTAAAGGTCACTCTGTGAGACTGCTGGGTCAGAAAAAGGATA ATGGAAGGCGGCTTGGGGGAGCACGATTGGATTTGCCGAAGATTAGGAAGAATCCACTGATAGAAATCATTTCCATCAATACCGGGTGTC TCAATGCTTGTACCTACTGCAAAACTAAACACGCCAGAGGAAATTTGGCCAGTTATCCAATTGATGAACTAGTAGATAGAGCCAAACAAT CTTTTCAAGAGGGTGTTTGTGAGATATGGTTGACCAGTGAAGACACGGGGGCTTATGGCAGAGATATTGGCACCAATCTCCCCACACTCC TGTGGAAACTGGTTGAAGTGATTCCTGAGGGAGCAATGCTGAGGCTTGGCATGACAAATCCGCCCTATATTTTAGAGCATCTGGAGGAAA TGGCAAAAATCCTTAATCACCCCAGAGTCTACGCTTTTCTGCACATACCAGTCCAGTCTGCCTCCGACAGCGTACTCATGGAAATGAAAA GAGAATACTGTGTGGCTGACTTCAAAAGAGTAGTGGATTTTCTGAAAGAGAAAGTTCCTGGAATAACTATTGCTACAGATATTATCTGTG GTTTTCCTGGAGAAACAGATCAGGATTTTCAAGAAACAGTGAAACTTGTTGAAGAGTACAAATTCCCAAGCCTGTTTATTAACCAATTTT ACCCAAGACCAGGAACTCCTGCTGCAAAAATGGAACAAGTTCCAGCACAAGTGGACGCACAAGACCAGCCACTGCTACCGCATCACGTAC CGCCACATGGAACGGACTCTGTCCCAGAGAGAGGTCAGGCACATCCACCAGGCCTTGCAGGAGGCTGCAGTCCAGCTGTTGGGTGTGGAG >15331_15331_1_CDKAL1-FARS2_CDKAL1_chr6_21065459_ENST00000274695_FARS2_chr6_5771524_ENST00000324331_length(amino acids)=458AA_BP=412 MPSASCDTLLDDIEDIVSQEDSKPQDRHFVRKDVVPKVRRRNTQKYLQEEENSPPSDSTIPGIQKIWIRTWGCSHNNSDGEYMAGQLAAY GYKITENASDADLWLLNSCTVKNPAEDHFRNSIKKAQEENKKIVLAGCVPQAQPRQDYLKGLSIIGVQQIDRVVEVVEETIKGHSVRLLG QKKDNGRRLGGARLDLPKIRKNPLIEIISINTGCLNACTYCKTKHARGNLASYPIDELVDRAKQSFQEGVCEIWLTSEDTGAYGRDIGTN LPTLLWKLVEVIPEGAMLRLGMTNPPYILEHLEEMAKILNHPRVYAFLHIPVQSASDSVLMEMKREYCVADFKRVVDFLKEKVPGITIAT DIICGFPGETDQDFQETVKLVEEYKFPSLFINQFYPRPGTPAAKMEQVPAQVDAQDQPLLPHHVPPHGTDSVPERGQAHPPGLAGGCSPA -------------------------------------------------------------- >15331_15331_2_CDKAL1-FARS2_CDKAL1_chr6_21065459_ENST00000378610_FARS2_chr6_5771524_ENST00000324331_length(transcript)=1385nt_BP=1246nt GGTAGAGAATATGCCTTCTGCATCCTGTGATACACTACTGGATGACATCGAAGATATCGTGTCTCAGGAAGATTCAAAACCACAAGATAG GCATTTTGTAAGAAAGGATGTTGTCCCGAAGGTACGAAGGCGAAATACCCAAAAATATTTGCAAGAGGAAGAAAACAGTCCACCAAGTGA CAGCACTATTCCAGGCATACAGAAAATTTGGATACGAACATGGGGTTGTTCTCATAATAATTCAGATGGAGAATATATGGCTGGACAGCT AGCTGCTTATGGCTATAAAATTACAGAAAATGCATCCGATGCAGATTTATGGCTCCTGAACAGTTGCACTGTAAAAAACCCAGCTGAAGA CCACTTTAGAAACTCAATTAAAAAAGCTCAAGAGGAGAACAAGAAAATCGTACTGGCTGGATGCGTTCCTCAAGCCCAGCCTCGCCAGGA CTACCTTAAGGGACTGAGTATCATTGGGGTTCAGCAGATAGATCGTGTGGTAGAAGTTGTGGAGGAGACAATTAAAGGTCACTCTGTGAG ACTGCTGGGTCAGAAAAAGGATAATGGAAGGCGGCTTGGGGGAGCACGATTGGATTTGCCGAAGATTAGGAAGAATCCACTGATAGAAAT CATTTCCATCAATACCGGGTGTCTCAATGCTTGTACCTACTGCAAAACTAAACACGCCAGAGGAAATTTGGCCAGTTATCCAATTGATGA ACTAGTAGATAGAGCCAAACAATCTTTTCAAGAGGGTGTTTGTGAGATATGGTTGACCAGTGAAGACACGGGGGCTTATGGCAGAGATAT TGGCACCAATCTCCCCACACTCCTGTGGAAACTGGTTGAAGTGATTCCTGAGGGAGCAATGCTGAGGCTTGGCATGACAAATCCGCCCTA TATTTTAGAGCATCTGGAGGAAATGGCAAAAATCCTTAATCACCCCAGAGTCTACGCTTTTCTGCACATACCAGTCCAGTCTGCCTCCGA CAGCGTACTCATGGAAATGAAAAGAGAATACTGTGTGGCTGACTTCAAAAGAGTAGTGGATTTTCTGAAAGAGAAAGTTCCTGGAATAAC TATTGCTACAGATATTATCTGTGGTTTTCCTGGAGAAACAGATCAGGATTTTCAAGAAACAGTGAAACTTGTTGAAGAGTACAAATTCCC AAGCCTGTTTATTAACCAATTTTACCCAAGACCAGGAACTCCTGCTGCAAAAATGGAACAAGTTCCAGCACAAGTGGACGCACAAGACCA GCCACTGCTACCGCATCACGTACCGCCACATGGAACGGACTCTGTCCCAGAGAGAGGTCAGGCACATCCACCAGGCCTTGCAGGAGGCTG >15331_15331_2_CDKAL1-FARS2_CDKAL1_chr6_21065459_ENST00000378610_FARS2_chr6_5771524_ENST00000324331_length(amino acids)=458AA_BP=412 MPSASCDTLLDDIEDIVSQEDSKPQDRHFVRKDVVPKVRRRNTQKYLQEEENSPPSDSTIPGIQKIWIRTWGCSHNNSDGEYMAGQLAAY GYKITENASDADLWLLNSCTVKNPAEDHFRNSIKKAQEENKKIVLAGCVPQAQPRQDYLKGLSIIGVQQIDRVVEVVEETIKGHSVRLLG QKKDNGRRLGGARLDLPKIRKNPLIEIISINTGCLNACTYCKTKHARGNLASYPIDELVDRAKQSFQEGVCEIWLTSEDTGAYGRDIGTN LPTLLWKLVEVIPEGAMLRLGMTNPPYILEHLEEMAKILNHPRVYAFLHIPVQSASDSVLMEMKREYCVADFKRVVDFLKEKVPGITIAT DIICGFPGETDQDFQETVKLVEEYKFPSLFINQFYPRPGTPAAKMEQVPAQVDAQDQPLLPHHVPPHGTDSVPERGQAHPPGLAGGCSPA -------------------------------------------------------------- >15331_15331_3_CDKAL1-FARS2_CDKAL1_chr6_21065459_ENST00000378624_FARS2_chr6_5771524_ENST00000324331_length(transcript)=1429nt_BP=1290nt AAATAAACGTGGCGGGACGTATGTGTCATGGCGCTCTCCATCTAAAGTCTGTGCAGCTTCCGGAGAGTGGCGGGTTGATTTTCTCACTTT GGACTGGTTTTTACTTCCCGACTTCTGGACTCATCTTTCAAGAGGACTTTAGACTAATTGCAGATAATTAAGAGAATATGCCTTCTGCAT CCTGTGATACACTACTGGATGACATCGAAGATATCGTGTCTCAGGAAGATTCAAAACCACAAGATAGGCATTTTGTAAGAAAGGATGTTG TCCCGAAGGTACGAAGGCGAAATACCCAAAAATATTTGCAAGAGGAAGAAAACAGTCCACCAAGTGACAGAAAATGCATCCGATGCAGAT TTATGGCTCCTGAACAGTTGCACTGTAAAAAACCCAGCTGAAGACCACTTTAGAAACTCAATTAAAAAAGCTCAAGAGGAGAACAAGAAA ATCGTACTGGCTGGATGCGTTCCTCAAGCCCAGCCTCGCCAGGACTACCTTAAGGGACTGAGTATCATTGGGGTTCAGCAGATAGATCGT GTGGTAGAAGTTGTGGAGGAGACAATTAAAGGTCACTCTGTGAGACTGCTGGGTCAGAAAAAGGATAATGGAAGGCGGCTTGGGGGAGCA CGATTGGATTTGCCGAAGATTAGGAAGAATCCACTGATAGAAATCATTTCCATCAATACCGGGTGTCTCAATGCTTGTACCTACTGCAAA ACTAAACACGCCAGAGGAAATTTGGCCAGTTATCCAATTGATGAACTAGTAGATAGAGCCAAACAATCTTTTCAAGAGGGTGTTTGTGAG ATATGGTTGACCAGTGAAGACACGGGGGCTTATGGCAGAGATATTGGCACCAATCTCCCCACACTCCTGTGGAAACTGGTTGAAGTGATT CCTGAGGGAGCAATGCTGAGGCTTGGCATGACAAATCCGCCCTATATTTTAGAGCATCTGGAGGAAATGGCAAAAATCCTTAATCACCCC AGAGTCTACGCTTTTCTGCACATACCAGTCCAGTCTGCCTCCGACAGCGTACTCATGGAAATGAAAAGAGAATACTGTGTGGCTGACTTC AAAAGAGTAGTGGATTTTCTGAAAGAGAAAGTTCCTGGAATAACTATTGCTACAGATATTATCTGTGGTTTTCCTGGAGAAACAGATCAG GATTTTCAAGAAACAGTGAAACTTGTTGAAGAGTACAAATTCCCAAGCCTGTTTATTAACCAATTTTACCCAAGACCAGGAACTCCTGCT GCAAAAATGGAACAAGTTCCAGCACAAGTGGACGCACAAGACCAGCCACTGCTACCGCATCACGTACCGCCACATGGAACGGACTCTGTC >15331_15331_3_CDKAL1-FARS2_CDKAL1_chr6_21065459_ENST00000378624_FARS2_chr6_5771524_ENST00000324331_length(amino acids)=388AA_BP=342 MLSRRYEGEIPKNICKRKKTVHQVTENASDADLWLLNSCTVKNPAEDHFRNSIKKAQEENKKIVLAGCVPQAQPRQDYLKGLSIIGVQQI DRVVEVVEETIKGHSVRLLGQKKDNGRRLGGARLDLPKIRKNPLIEIISINTGCLNACTYCKTKHARGNLASYPIDELVDRAKQSFQEGV CEIWLTSEDTGAYGRDIGTNLPTLLWKLVEVIPEGAMLRLGMTNPPYILEHLEEMAKILNHPRVYAFLHIPVQSASDSVLMEMKREYCVA DFKRVVDFLKEKVPGITIATDIICGFPGETDQDFQETVKLVEEYKFPSLFINQFYPRPGTPAAKMEQVPAQVDAQDQPLLPHHVPPHGTD -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CDKAL1-FARS2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CDKAL1-FARS2 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CDKAL1-FARS2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CDKAL1 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 3 | CTD_human |
Hgene | CDKAL1 | C0005910 | Body Weight | 2 | CTD_human |
Hgene | CDKAL1 | C0005612 | Birth Weight | 1 | CTD_human |
Hgene | CDKAL1 | C0263859 | Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome | 1 | CTD_human |
Tgene | C0023264 | Leigh Disease | 7 | CLINGEN | |
Tgene | C1838951 | LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY | 7 | CLINGEN | |
Tgene | C1850597 | Leigh Syndrome Due To Mitochondrial Complex II Deficiency | 7 | CLINGEN | |
Tgene | C1850598 | Leigh Syndrome due to Mitochondrial Complex III Deficiency | 7 | CLINGEN | |
Tgene | C1850599 | Leigh Syndrome due to Mitochondrial Complex IV Deficiency | 7 | CLINGEN | |
Tgene | C1850600 | Leigh Syndrome due to Mitochondrial Complex V Deficiency | 7 | CLINGEN | |
Tgene | C2931891 | Necrotizing encephalopathy, infantile subacute, of Leigh | 7 | CLINGEN | |
Tgene | C3554168 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14 | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C4310750 | SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |